Phenotypic diversity and emerging new tools to study macrophage activation in bacterial infectious diseases

Frontiers in Immunology

Volumn 5, Issue OCT, 2014, Pages

  Ka, Mignane B ^a   Daumas, Aurélie ^a   Textoris, Julien ^b   Mege, Jean Louis ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Activation; Bacteria; Infectious diseases; Macrophage; Polarization

Indexed keywords

CHEMOKINE; CYTOKINE; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 4;

BACTERIAL INFECTION; DNA TRANSCRIPTION; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; INTESTINE LIPODYSTROPHY; LEPROSY; LIPID METABOLISM; MACROPHAGE ACTIVATION; MEMBRANE POLARIZATION AND DEPOLARIZATION; MICROFLORA; NONHUMAN; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; Q FEVER; REVIEW; SEPSIS; TUBERCULOSIS;

EID: 84918788369     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00500     Document Type: Review

References (55)

1. Mills CD, Ley K. M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun (2014). doi:10.1159/000364945
2. Kidd BA, Peters LA, Schadt EE, Dudley JT. Unifying immunology with informatics and multiscale biology. Nat Immunol (2014) 15(2):118-27. doi:10.1038/ni0914-894c
3. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol (2006) 177(10):7303-11. doi:10.4049/jimmunol.177.10.7303
4. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity (2014) 40(2):274-88. doi:10.1016/j.immuni.2014.01.006
5. Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol (2014) 14(2):81-93. doi:10.1038/nri3600
6. Brown J, Wallet MA, Krastins B, Sarracino D, Goodenow MM. Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages. J Leukoc Biol (2010) 87(4):655-62. doi:10.1189/jlb.0809570
7. Ouedraogo R, Flaudrops C, Ben Amara A, Capo C, Raoult D, Mege JL. Global analysis of circulating immune cells by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. PLoS One (2010) 5(10):e13691. doi:10.1371/journal.pone.0013691
8. Ouedraogo R, Daumas A, Ghigo E, Capo C, Mege JL, Textoris J. Whole-cell MALDI-TOF MS: a new tool to assess the multifaceted activation of macrophages. J Proteomics (2012) 75(18):5523-32. doi:10.1016/j.jprot.2012.07.046
9. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity (2014) 41(1):14-20. doi:10.1016/j.immuni.2014.06.008
10. Barros MH, Hauck F, Dreyer JH, Kempkes B, Niedobitek G. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One (2013) 8(11):e80908. doi:10.1371/journal.pone.0080908
11. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol (2000) 67(1):97-103. doi:10.1189/jlb.0813437
12. Kittan NA, Allen RM, Dhaliwal A, Cavassani KA, Schaller M, Gallagher KA, et al. Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PLoS One (2013) 8(10):e78045. doi:10.1371/journal.pone.0078045
13. Mehraj V, Textoris J, Ben Amara A, Ghigo E, Raoult D, Capo C, et al. Monocyte responses in the context of Q fever: from a static polarized model to a kinetic model of activation. J Infect Dis (2013) 208(6):942-51. doi:10.1093/infdis/jit266
14. Ivanov II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe (2012) 12(4):496-508. doi:10.1016/j.chom.2012.09.009
15. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol (2010) 10(3):159-69. doi:10.1038/nri2710
16. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 9(5):313-23. doi:10.1038/nri2515
17. Smith PD, Ochsenbauer-Jambor C, Smythies LE. Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev (2005) 206:149-59. doi:10.1111/j.0105-2896.2005.00288.x
18. Jones SE, Paynich ML, Kearns DB, Knight KL. Protection from intestinal inflammation by bacterial exopolysaccharides. J Immunol (2014) 192(10):4813-20. doi:10.4049/jimmunol.1303369
19. Hayashi A, Sato T, Kamada N, Mikami Y, Matsuoka K, Hisamatsu T, et al. A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe (2013) 13(6):711-22. doi:10.1016/j.chom.2013.05.013
20. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A (2014) 111(6):2247-52. doi:10.1073/pnas.1322269111
21. Yang Y, Wang X, Huycke T, Moore DR, Lightfoot SA, Huycke MM. Colon macrophages polarized by commensal bacteria cause colitis and cancer through the bystander effect. Transl Oncol (2013) 6(5):596-606. doi:10.1593/tlo.13412
22. Jang SE, Hyam SR, Han MJ, Kim SY, Lee BG, Kim DH. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages. J Appl Microbiol (2013) 115(3):888-96. doi:10.1111/jam.12273
23. Christoffersen TE, Hult LT, Kuczkowska K, Moe KM, Skeie S, Lea T, et al. In vitro comparison of the effects of probiotic, commensal and pathogenic strains on macrophage polarization. Probiotics Antimicrob Proteins (2014) 6(1):1-10. doi:10.1007/s12602-013-9152-0
24. Habil N, Al-Murrani W, Beal J, Foey AD. Probiotic bacterial strains differentially modulate macrophage cytokine production in a strain-dependent and cell subset-specific manner. Benef Microbes (2011) 2(4):283-93. doi:10.3920/BM2011.0027
25. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol (2008) 181(6):3733-9. doi:10.4049/jimmunol.181.6.3733
26. Mege JL, Mehraj V, Capo C. Macrophage polarization and bacterial infections. Curr Opin Infect Dis (2011) 24(3):230-4. doi:10.1097/QCO.0b013e328344b73e
27. Quiding-Jarbrink M, Raghavan S, Sundquist M. Enhanced M1 macrophage polarization in human Helicobacter pylori-associated atrophic gastritis and in vaccinated mice. PLoS One (2010) 5(11):e15018. doi:10.1371/journal.pone.0015018
28. Kim YG, Udayanga KG, Totsuka N, Weinberg JB, Nunez G, Shibuya A. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2. Cell Host Microbe (2014) 15(1):95-102. doi:10.1016/j.chom.2013.12.010
29. Chen J, Ivashkiv LB. IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc Natl Acad Sci U S A (2010) 107(45):19438-43. doi:10.1073/pnas.1007816107
30. Wilson HM. SOCS proteins in macrophage polarization and function. Front Immunol (2014) 5:357. doi:10.3389/fimmu.2014.00357
31. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med (2003) 348(2):138-50. doi:10.1056/NEJMra021333
32. Brunialti MK, Santos MC, Rigato O, Machado FR, Silva E, Salomao R. Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis. PLoS One (2012) 7(5):e37393. doi:10.1371/journal.pone.0037393
33. Moller HJ, Moestrup SK, Weis N, Wejse C, Nielsen H, Pedersen SS, et al. Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163. Crit Care Med (2006) 34(10):2561-6. doi:10.1097/01.CCM.0000239120.32490.AB
34. Kjaergaard AG, Rodgaard-Hansen S, Dige A, Krog J, Moller HJ, Tonnesen E. Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients. PLoS One (2014) 9(3):e92331. doi:10.1371/journal.pone.0092331
35. Rodgaard-Hansen S, Rafique A, Christensen PA, Maniecki MB, Sandahl TD, Nexo E, et al. A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. Clin Chem Lab Med (2014) 52(3):453-61. doi:10.1515/cclm-2013-0451
36. Raoult D, Marrie T, Mege JL. Natural history and pathophysiology of Q fever. Lancet Infect Dis (2005) 5(4):219-26. doi:10.1016/S1473-3099(05)70052-9
37. Benoit M, Barbarat B, Bernard A, Olive D, Mege JL. Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages. Eur J Immunol (2008) 38(4):1065-70. doi:10.1002/eji.200738067
38. Ben Amara A, Bechah Y, Mege JL. Immune response and Coxiella burnetii invasion. Adv Exp Med Biol (2012) 984:287-98. doi:10.1007/978-94-007-4315-1_15
39. Rajaram MV, Brooks MN, Morris JD, Torrelles JB, Azad AK, Schlesinger LS. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. J Immunol (2010) 185(2):929-42. doi:10.4049/jimmunol.1000866
40. Ghigo E, Capo C, Raoult D, Mege JL. Interleukin-10 stimulates Coxiella burnetii replication in human monocytes through tumor necrosis factor down-modulation: role in microbicidal defect of Q fever. Infect Immun (2001) 69(4):2345-52. doi:10.1128/IAI.69.4.2345-2352.2001
41. Ghigo E, Honstettre A, Capo C, Gorvel JP, Raoult D, Mege JL. Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever. J Infect Dis (2004) 190(10):1767-72. doi:10.1086/425041
42. Benoit M, Ghigo E, Capo C, Raoult D, Mege JL. The uptake of apoptotic cells drives Coxiella burnetii replication and macrophage polarization: a model for Q fever endocarditis. PLoS Pathog (2008) 4(5):e1000066. doi:10.1371/journal.ppat.1000066
43. Meghari S, Bechah Y, Capo C, Lepidi H, Raoult D, Murray PJ, et al. Persistent Coxiella burnetii infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis. PLoS Pathog (2008) 4(2):e23. doi:10.1371/journal.ppat.0040023
44. Meghari S, Berruyer C, Lepidi H, Galland F, Naquet P, Mege JL. Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection. Eur J Immunol (2007) 37(1):24-32. doi:10.1002/eji.200636054
45. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature (2010) 466(7309):973-7. doi:10.1038/nature09247
46. Fletcher HA, Keyser A, Bowmaker M, Sayles PC, Kaplan G, Hussey G, et al. Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth. BMC Med Genomics (2009) 2:10. doi:10.1186/1755-8794-2-10
47. Tang Y, Hua SC, Qin GX, Xu LJ, Jiang YF. Different subsets of macrophages in patients with new onset tuberculous pleural effusion. PLoS One (2014) 9(2):e88343. doi:10.1371/journal.pone.0088343
48. Montoya D, Cruz D, Teles RM, Lee DJ, Ochoa MT, Krutzik SR, et al. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe (2009) 6(4):343-53. doi:10.1016/j.chom.2009.09.002
49. Desnues B, Lepidi H, Raoult D, Mege JL. Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2/alternatively activated macrophages. J Infect Dis (2005) 192(9):1642-6. doi:10.1086/491745
50. Moos V, Schmidt C, Geelhaar A, Kunkel D, Allers K, Schinnerling K, et al. Impaired immune functions of monocytes and macrophages in Whipple's disease. Gastroenterology (2010) 138(1):210-20. doi:10.1053/j.gastro.2009.07.066
51. Geelhaar-Karsch A, Schinnerling K, Conrad K, Friebel J, Allers K, Schneider T, et al. Evaluation of arginine metabolism for the analysis of M1/M2 macrophage activation in human clinical specimens. Inflamm Res (2013) 62(9):865-9. doi:10.1007/s00011-013-0642-z
52. Al Moussawi K, Ghigo E, Kalinke U, Alexopoulou L, Mege JL, Desnues B. Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei. PLoS Pathog (2010) 6(1):e1000722. doi:10.1371/journal.ppat.1000722
53. Desnues B, Raoult D, Mege JL. IL-16 is critical for Tropheryma whipplei replication in Whipple's disease. J Immunol (2005) 175(7):4575-82. doi:10.4049/jimmunol.175.7.4575
54. Rayamajhi M, Humann J, Kearney S, Hill KK, Lenz LL. Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections. Virulence (2010) 1(5):418-22. doi:10.4161/viru.1.5.12787
55. Honstettre A, Imbert G, Ghigo E, Gouriet F, Capo C, Raoult D, et al. Dysregulation of cytokines in acute Q fever: role of interleukin-10 and tumor necrosis factor in chronic evolution of Q fever. J Infect Dis (2003) 187(6):956-62. doi:10.1086/368129